Smoking cessation support delivered via mobile phones increases chances that people living with HIV who smoke will quit, according to research published in the online edition of Clinical Infectious Diseases. Overall, people receiving mobile phone-based support were over two times more likely to stop smoking than people receiving the standard of care. “The use of proactive

A large US study has provided important new insights into the incidence and timing of cancers among people taking antiretroviral therapy. Published in the online edition of Clinical Infectious Diseases, the study showed that incidence of AIDS-defining cancers was highest in the six months after starting HIV therapy and then fell dramatically. In contrast,

HIV therapy that effectively controls viral load reduces the risk of anal cancer, US research published in the online edition of the Journal of Acquired Immune Deficiency Syndromes shows. The retrospective study involved almost 29,000 men taking combination antiretroviral therapy. Men with viral suppression for at least 60% of the time while taking treatment

High-grade pre-cancerous anal lesions are more likely to regress than progress, according to Australian research published in the online edition of AIDS. The study involved 574 men, three-quarters of whom were HIV positive. Only 1% of patients progressed to anal cancer, compared to a regression rate of 24%. “Our data provide reassurance that high-grade ASILs [anal

Ugandan women who have been subject to violence from a sexual partner are more likely than other women to go on to acquire HIV, according to a large, longitudinal study from the Rakai cohort, published in the May 15 issue of AIDS. Women who had experienced more severe forms of violence, more frequently, or